United States · Funded startup
5 rounds we have observed, with the 16 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$99Mraised across 5 rounds since 2005, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by sec.govSEC filing: $867K sold, first sale Jan 2013
No investor was named in the report.
Reported by sec.govSEC filing: $16M sold, first sale May 2010
Morningside Group
Novartis Venture Fund
Mitsui & Co
Lilly Ventures
Bioventures InvestorsReported by socaltech.comSEC filing: $6.1M sold, first sale May 2010
Mitsui Global InvestmentBioventures Investors
William Harris InvestorsFrom a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Bioventures InvestorsHBM BioVenturesMitsui Global InvestmentLilly VenturesMorningside GroupNovartis Venture Fund
Sanderling VenturesMitsui & CoCelgeneNovartis BioventuresMissing a round, or an investor who was in one? Tell us.
Cylene Pharmaceuticals's investors include Bioventures Investors, HBM BioVentures, Mitsui Global Investment, Lilly Ventures and Morningside Group, and 11 more on record.
Cylene Pharmaceuticals has raised $99M across 5 rounds since 2005.
Cylene Pharmaceuticals's most recent round was a Debt of $867K in Jan 2013.
Cylene Pharmaceuticals's largest round on record is $44M (Series C), in Jan 2007.
Cylene Pharmaceuticals's first round on record, in May 2005, was backed by Mitsui Global Investment, Bioventures Investors and Viterbi Group and 3 others.
Cylene Pharmaceuticals's latest named round is a Debt, in Jan 2013.
Cylene Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 